WO2021239478A1

WO2021239478A1 - Sunscreen with a combination of waxes, cetyl palmitate and hydrogenated rapeseed oil

Info

Publication number: WO2021239478A1
Application number: PCT/EP2021/062838
Authority: WO
Inventors: Lisa JESKE; Christina Japp; Heike VOLBRICH; Stephanie Von Der Fecht; Alexis Goulet-Hanssens
Original assignee: Beiersdorf Ag
Priority date: 2020-05-28
Filing date: 2021-05-14
Publication date: 2021-12-02
Also published as: DE102020206714A1

Abstract

The present invention relates to a cosmetic preparation containing a) one or more UV filters, b) cetyl palmitate (INCI: Cetyl Palmitate) and c) a wax having a melting point of 68-80 °C, d) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil), wherein the weight ratio of cetyl palmitate to wax having a melting point of 68-80 °C is 0.4 to 2.5, and to methods and uses of cetyl palmitate und waxes having a melting point of 68-80 °C in cosmetic sunscreen agents.

Description

Sunscreen with a combination of waxes, cetyl palmitate and hydrogenated

Rapeseed oil

The present invention relates to a cosmetic preparation containing a) one or more UV filters, b) cetyl palmitate (INCI: Cetyl Palmitate) and c) a wax with a melting point of 68-80 ° C. and d) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil), the weight ratio of cetyl palmitate to wax with a melting point of 68-80 ° C being from 0.4 to 2.5, as well as processes and uses of cetyl palmitate and waxes with a melting point of 68-80 ° C in cosmetic sunscreens.

The trend away from the elegant paleness towards "healthy, sporty brown skin" has been unbroken for years. In order to achieve this, people expose their skin to solar radiation, as this causes pigment formation in the sense of melanin. However, the ultraviolet radiation of sunlight also has a damaging effect on the skin. In addition to acute damage (sunburn), long-term damage such as an increased risk of developing skin cancer occurs when exposed to excessive exposure to light from the UVB range (wavelength: 280-320 nm). The excessive exposure to UVB and UVA radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous phototoxic and photoallergic reactions and leads to premature aging of the skin.

To protect the skin, a number of light protection filter substances have therefore been developed that can be used in cosmetic preparations. These UVA and UVB filters are summarized in most industrialized countries in the form of positive lists such as Appendix 7 of the Cosmetics Ordinance. The large number of commercially available sunscreens should not, however, obscure the fact that these prior art preparations have a number of disadvantages.

A widespread form of use of cosmetic sunscreens takes place around water sports. The sunscreens are often used in connection with beach vacations, visits to swimming pools, bathing, surfing, diving, paddling or other activities in which the human skin comes into contact with water.

In all of these activities, for comprehensive UV protection it is important that the sunscreen has a certain water resistance and is not rinsed off the skin immediately upon contact with the water.

In order to increase the water resistance of cosmetic sunscreens, so-called film formers are generally added to these preparations. The film formers are usually polymeric compounds based on polyacrylates or polyvinylpyrrolidones, which form a protective film on the skin which is intended to prevent / delay the washing of the UV filters from the skin.

The use of such film formers is viewed increasingly critically by a broader public. In the public discussion, the concern is often expressed that polymeric film formers, analogous to so-called “microplastics”, can represent a burden on the environment. Whether such concerns are justified and scientifically justified can be left open in the context of the present disclosure. The fact is, however, that there is increasing interest among cosmetics manufacturers and consumers in developing alternative techniques for ensuring the water resistance of sunscreens.

It was therefore the object of the present invention to develop a sunscreen which is as waterproof as possible and in which the use of polymeric film formers (in particular those based on polyacrylates and polyvinylpyrrolidones) can be largely dispensed with.

The object is surprisingly achieved by a cosmetic preparation containing a) one or more UV filters, b) cetyl palmitate (INCI: Cetyl Palmitate), c) a wax with a melting point of 68-80 ° C and d) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil). wherein the weight ratio of cetyl palmitate to wax with a melting point of 68-80 ° C is from 0.4 to 2.5.

In the investigations on which the present invention is based, it was found that, contrary to expectations, the sun protection factor SPF on the skin treated with the preparation according to the invention is reached or does not decrease but rather increases on contact with water. This sun protection factor, also known as SPW, which is determined on contact with water, is determined using the following method:

In Vivo Determination of Sun Protection International Standard ISO 24444; 2010, Sun Product Very Water Resistance -Spa Pool, COLIPA 2005

According to the invention, therefore, a method for increasing the sun protection factor SPF when bathing in water, characterized in that a sunscreen containing a) cetyl palmitate (INCI: Cetyl palmitate), b) a wax with a melting point of 68-80 ° C is used before bathing and c) applying hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) to the skin in a weight ratio of cetyl palmitate to wax with a melting point of 68-80 ° C. of 0.4 to 2.5.

According to the invention, the use of a combination of a) cetyl palmitate (INCI: Cetyl Palmitate), b) a wax with a melting point of 68-80 ° C and c) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil), in a weight ratio of cetyl palmitate to Wax with a melting point of 68-80 ° C from 0.45 to 2.5, to increase the sun protection factor SPF of cosmetic sunscreens in water, as well as the use of a combination of a) cetyl palmitate (INCI: Cetyl Palmitate), b) a wax with a Melting point of 68-80 ° C and c) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil), in a weight ratio of cetyl palmitate to wax with a melting point of 68-80 ° C from 0.45 to 2.5, to increase the water resistance of cosmetic Sunscreen.

The formulations “according to the invention”, “advantageous according to the invention” etc. always relate in the context of the present disclosure to the sunscreen composition according to the invention, the uses according to the invention and the method according to the invention if it is in the Individual cases are not described differently. The melting points are determined at normal pressure (1.013 bar). According to the invention, UV filters are all substances that are listed as UV filters in Regulation (EU) No. 866/2014 and Regulation No. 1223/2009 of the EU Commission in Annex VI.

According to the invention, it is advantageous if the wax with a melting point of 68-80 ° C is sunflower wax (INCI: Fleliantus Annuus Seed Cera), Phytowax (INCI: Castor Flydrogenated Cetyl Castor Esters or Flydrogenated Behenyl Castor Esters) Candelilla Wax (INCI: Candelilla Wax) , Cosmetik Wax A4 (INCI: Flydrogenated Vegetable Oil) or Syncrowax (INCI: C18-C36 Acid Triglyceride) can be used.

According to the invention, the use of sunflower wax (INCI: Fleliantus Annuus Seed Cera) is particularly preferred.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation has one or more UV filters selected from the group of the compounds 4- (tert-butyl) -4'-methoxydibenzoylmethane (INCI butyl methoxydibenzoylmethane), (2- [ -4- (Diethylamino) -2-hydroxybenzoyl] benzoic acid hexyl ester (INCI: Diethyl-amino Flydroxybenzoyl Flexyl Benzoate) and 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6 - (4-methoxyphenyl) -1, 3,5-triazine (INCI Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine) contains.

If the preparation contains 4- (tert-butyl) -4’-methoxydibenzoylmethane (INCI Butyl Methoxydibenzoylmethane), the advantageous according to the invention is 1 to 5% by weight, based on the total weight of the preparation.

If the preparation contains (2 - [- 4- (diethylamino) -2-hydroxybenzoyl] benzoic acid hexyl ester (INCI: Diethylamino Flydroxybenzoyl Flexyl Benzoate), the use concentration advantageous according to the invention is from 1 to 9% by weight, based on the total weight of the preparation.

If the preparation contains 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI bis-ethylhexyloxyphenol methoxyphenyl Triazines), the use concentration advantageous according to the invention is from 0.5 to 4.5% by weight based on the total weight of the preparation.

Furthermore, embodiments advantageous according to the invention are characterized in that they contain one or more UV filters selected from the group of the compounds 2-phenylbenzimidazole-5-sulfonic acid salts; Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene and its salts; 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulphonic acid salts; 2,2'-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol);

2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] -phenol; Ethyl hexyl salicylate; Terephthalidicamphorsulfonic acid salts; 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate; 4- (dimethylamino) benzoic acid amyl ester; 4-methoxybenzalmalonic acid di (2-ethylhexyl) ester; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; Homomenthyl salicylate; 2-ethylhexyl 2-hydroxybenzoate; Dimethicodiethylbenzalmalonate; 3- (4- (2,2- bis ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane - copolymer; Dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone); 2,4-bis- [5-1 (dimethyl-propyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine with the ( CAS No. 288254-16-0); 4,4 ', 4 "- (1, 3,5-triazine-2,4,6-triyltriimino) -tris-benzoic acid-tris (2-ethylhexyl ester) (also: 2, 4, 6-tris- [anilino- (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: Ethylhexyl Triazone); 2,4,6-T ribiphenyl-4-yl-1, 3,5- triazine; merocyanines; piperazine derivatives; titanium dioxide; zinc oxide.

In particular, the use of phenylbenzimidazole-5-sulfonic acid salts, ethylhexyl salicylate, homomenthyl salicylate, 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate, dioctylbutylamidotriazone (INCI: Diethylhexyl-Butamidotriazone), 4,4 ', 4 "- 3,5-Triazine-2,4,6-triyltriimino) -tris-benzoic acid-tris (2-ethylhexyl ester) (INCI: Ethylhexyl Triazone), titanium dioxide preferred according to the invention. Particularly preferred according to the invention are the UV filters phenylbenzimidazole-5-sulfonic acid salts, Ethylhexyl salicylate, dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone), 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) -tris-benzoic acid-tris (2-ethylhexyl ester) (INCI: Ethylhexyl triazone).

The preferred use concentrations according to the invention for phenylbenzimidazole-5-sulfonic acid salts are from 0.5 to 4% by weight, based on the total weight of the preparation, the preferred use concentration for ethylhexyl salicylate is from 0.5 to 5% by weight, based on the total weight .

It is advantageous for the purposes of the present invention if the preparation contains one or more UV filters a) in a total concentration of 1 to 30% by weight, based on the total weight of the preparation.

According to the invention, the preparation according to the invention can advantageously be present in different product forms.

In a first advantageous embodiment, the preparation is in the form of a spray. In this case, the embodiment advantageous according to the invention is characterized in that the spray formulation

Cetyl palmitate (INCI: Cetyl Palmitate) in a concentration of 0.1 to 2.5% by weight, a wax with a melting point of 68-80 ° C in a concentration of 0.1 to 2.5% by weight and contains hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) in a concentration of 0.5 to 3.5% by weight, based in each case on the total weight of the preparation.

If the preparation according to the invention is in the form of an emulsion spray, according to the invention it preferably has a viscosity of 800 to 2500 mPas, 800, measured with the Rheomat R 123 device, at a temperature of 25 ° C., with measuring body no.1 after 30 Seconds.

In particular due to the fact that waxes usually increase the viscosity of the preparation so much that it can no longer be sprayed, it was surprising that a spray can be produced with the substance combination according to the invention.

In a second advantageous embodiment, the preparation can be in the form of an emulsion lotion. In such a case it is advantageous according to the invention if the emulsion cetyl palmitate (INCI: Cetyl Palmitate) in a concentration of 0.1 to 2.5% by weight, a wax with a melting point of 68-80 ° C. in one concentration from 0.5 to 3.5% by weight and hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) in a concentration of 0.5% to 3% by weight, each based on the total weight of the preparation.

The type of emulsion which is advantageous according to the invention is the O / W emulsion. If the preparation according to the invention is in the form of an O / W emulsion, it is advantageously characterized according to the invention in that the preparation has one or more O / W emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, Contains polyglyceryl 3-methylglycose distearate, sodium cetearyl sulfate, potassium cetyl phosphate, polyglyceryl 10 stearate, sodium stearyl glutamate.

In all application forms, it is preferred according to the invention if the weight ratio of cetyl palmitate to wax with a melting point of 68-80 ° C. is from 0.45 to 1.5.

It is advantageous according to the invention if the preparation contains xanthan gum (INCI: Xanthan Gum). In such a case, the embodiments preferred according to the invention are characterized in that the preparation contains xanthan gum (INCI: Xanthan Gum) in a concentration of 0.01 to 0.5% by weight, based on the total weight of the preparation.

Advantageous embodiments within the meaning of the present invention are characterized in that the preparation contains phenoxyethanol, ethylhexylglycerol and / or 4-hydroxyacetophenone.

It is also advantageous according to the invention if the preparation contains one or more alkanediols from the group of compounds 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, 2-methyl-1,3 -propanediol contains.

In addition, it is advantageous according to the invention if the preparation is free from 3- (4-methylbenzylidene) camphor, 2-hydroxy-4-methoxybenzophenone (INCI: Oxybenzon), 4-methoxycinnamic acid-2-ethylhexyl ester (INCI Octylmethoxycinnamate), parabens (especially Propyl and butyl paraben), methyl isothiazolinone, chloromethyl isothiazolinone and DMDM hydantoin, polyethylene glycol ethers or polyethylene glycol esters.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation has one or more compounds selected from the group of compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosyl rutin, carnitine, carnosine, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, b-alanine, panthenol, magnolol, honokiol, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or its salts and / or licochalcone A contains.

The preparation according to the invention can advantageously contain humectants. Moisturizers are substances or mixtures of substances which give cosmetic preparations the property of reducing the release of moisture from the horny layer (also called transepidermal water loss (TEWL)) and / or reducing the hydration of the skin after application or distribution on the skin surface To positively influence the horny layer.

Advantageous moisturizers for the purposes of the present invention are, for example, glycerol, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, Biosaccaride Gum-1, Glycine soy, ethylhexyloxyglycerol, pyrrolidone carboxylic acid and urea. It is also particularly advantageous to use polymeric To use moisturizers from the group of water-soluble and / or water-swellable and / or water-gellable polysaccharides. For example, hyaluronic acid, chitosan and / or a fucose-rich polysaccharide, which is filed in the Chemical Abstracts under the registry number 178463-23-5 and z. B. is available under the name Fucogel®1000 from SOLABIA SA. Moisturizers can also be used advantageously as anti-wrinkle ingredients to protect against skin changes such as those caused by skin changes. B. occur in skin aging can be used.

The cosmetic preparations according to the invention can also advantageously, although not necessarily, contain fillers which, for. B. further improve the sensory and cosmetic properties of the formulations and, for example, induce or intensify a velvety or silky feel on the skin. Advantageous fillers for the purposes of the present invention are starch and starch derivatives (such as tapioca starch, distarch phosphate, aluminum or sodium starch, octenyl succinate and the like),

Pigments, which neither mainly have a UV filter nor a coloring effect (such as boron nitride etc.) and / or Aerosile ^® (CAS No. 7631-86-9) and / or talc and / or polyethylene, nylon.

It is preferred according to the invention if the preparation according to the invention contains tapioca starch and / or distarch phosphate.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation has one or more oils selected from the group of the compounds butylene glycol dicaprylate / dicaprate, phenethyl benzoate, C12-15 alkyl benzoate, dibutyl adipate; Diisopropyl sebacate, dicaprylyl carbonate, di-C12-13 alkyl tartrates, butyloctyl salicylate, diethylhexyl syringylidene malonate, hydragnated castor oil dimerate, triheptanoin, C12-13 alkyl lactate, C16-17, alkyl benzoate, propylheptyl caprylate, diethylhexyl caprylide, 2.6 caprylic caprylate - Contains naphthalate, octyldodecanol, caprylic / capric triglyceride, ethylhexyl cocoate.

It is preferred according to the invention if the preparation contains dibutyl adipate, dicaprylyl carbonate, butylene glycol dicaprylate / dicaprate and / or C12-C15 alkyl benzoate.

The water phase of the preparations according to the invention can advantageously contain customary cosmetic auxiliaries, such as alcohols, in particular those with a low carbon number, preferably ethanol and / or isopropanol or polyols with a low carbon number, and their ethers, preferably propylene glycol, glycerol, electrolytes, self-tanners and, in particular, a or more thickeners, which or which can advantageously be selected from the group silicon dioxide, aluminum silicates, polysaccharides or their derivatives, e.g. B. hyaluronic acid, hydroxypropylmethyl cellulose. It is also advantageous in the context of the present invention if the preparation according to the invention has one or more perfumes selected from the group of the compounds limonene, citral, linalool, alpha-isomethylionone, geraniol, citronellol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert-pentylcyclohexyl acetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1, 1, 3,4,4,6-hexamethyltetralin, adipic acid diester, alpha-amylcinnamaldehyde, alpha

Methyl ionone, amyl C Butylphenylmethylpropionalcinnamal, amyl salicylate, Amylcinnamylalkohol, anisyl alcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, Butylphenylmethylpropioal, Cardamom oil, cedrol, cinnamal, cinnamyl alcohol, Citronellylmethylcrotonat, lemon oil, coumarin, diethyl succinate, ethyl linalool, eugenol, Evernia Furfuracea Extract, Evernia Prunastri Extract, Farnesol, guaiac wood oil, hexylcinnamal, hexyl salicylate, hydroxycitronellal, lavender oil, lemon oil, linaylacetate, mandarin oil, menthyl PCA, methylheptenone, nutmeg oil, rosemary oil, and / or, contains triethylenet oil. In addition, the preparations according to the invention which are used for cosmetic

Sunscreens contain the usual ingredients in the usual concentrations.

Comparative experiment

The effect according to the invention could be demonstrated with the following comparative experiment. The following recipes were made.

Examples

The following examples are intended to illustrate the present invention without restricting it. Unless otherwise stated, all quantities, proportions and percentages are based on the weight and the total amount or the total weight of the preparations.

Examples [%]

Claims

1. Cosmetic preparation containing a) one or more UV filters, b) cetyl palmitate (INCI: Cetyl Palmitate), c) a wax with a melting point of 68-80 ° C, the weight ratio of cetyl palmitate to wax with a melting point of 68 -80 ° C from 0.45 to 2.5 and d) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil).

2. A method for increasing the sun protection factor SPF when bathing in water, characterized in that before bathing a sunscreen containing a) cetyl palmitate (INCI: Cetyl Palmitate), b) a wax with a melting point of 68-80 ° C and c) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil), in a weight ratio of cetyl palmitate to wax with a melting point of 68-80 ° C from 0.4 to 2.5 on the flaut.

3. Use of a combination of a) cetyl palmitate (INCI: Cetyl Palmitate), b) a wax with a melting point of 68-80 ° C and c) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil), in a weight ratio of cetyl palmitate to the wax a melting point of 68-75 ° C from 0.4 to 2.5, to increase the sun protection factor SPF of cosmetic sunscreens in water.

4. Use of a combination of a) cetyl palmitate (INCI: Cetyl Palmitate) and b) a wax with a melting point of 68-80 ° C and c) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil), in a weight ratio of cetyl palmitate to the wax a melting point of 68-80 ° C from 0.4 to 2.5, to increase the water resistance of cosmetic sunscreens.

5. Cosmetic preparation according to claim 1, method according to claim 2 or use according to claim 3 or 4, characterized in that the wax with a melting point of 68-80 ° C is sunflower wax (INCI: Heliantus Annuus Seed Cera), Phytowax (INCI: Castor Hydrogenated Cetyl Castor Esters or Hydrogenated Behenyl Castor Esters), Candelilla Wax (INCI: Candelilla Wax), Glycerol tristearate (INCI: Tristearin), (INCI: Cosmetik Wax A4 (INCI: Hydrogenated Vegetable Oil) or Syncrowax (INCI: C18-C36 Acid Glycol Ester) can be used.

6. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that sunflower wax (INCI: Heliantus Annuus Seed Cera) is used as the wax with a melting point of 68-80 ° C.

7. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation has one or more UV filters selected from the group of compounds 4- (tert-butyl) -4'-methoxydiben- zoylmethane (INCI butyl Methoxydibenzoylmethane), (2 - [- 4- (Diethylamino) -2-hydroxybenzoyl] benzoic acid hexyl ester (INCI: Diethylamino Hydroxybenzoyl Hexyl Benzoate) and 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -

1, 3,5-triazine (INCI Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine) contains.

8. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that it contains one or more UV filters selected from the group of the compounds 2-phenylbenzimidazole-5-sulfonic acid salts; Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene and its salts; 4- (2-oxo-3-bornylidenemethyl) benzene sulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] phenol; Ethyl hexyl salicylate; Terephthalidicamphorsulfonic acid salts; 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate; 4- (dimethylamino) benzoic acid amyl ester; 4-methoxybenzalmalonic acid di (2-ethylhexyl) ester; Isoamyl 4-methoxycinnamate; 2-flydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; 2- (4'-Diethylamino-2'-hydroxybenzoyl) -benzoic acid hexyl ester; Flomomenthyl salicylate; 2-ethylhexyl 2-hydroxybenzoate; Dimethicodiethylbenzalmalonate; 3- (4- (2,2- bis ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer; Dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone); 2,4-bis- [5-1 (dimethyl-propyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine with the ( CAS No. 288254-16-0); 4,4 ', 4 "- (1, 3,5-triazine-2,4,6-triyltriimino) -tris-benzoic acid-tris (2-ethylhexyl ester) (also: 2, 4, 6-tris- [anilino- (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: Ethylhexyl Triazone); 2,4,6-T ribiphenyl-4-yl-1, 3,5- triazine; merocyanines; piperazine derivatives; titanium dioxide; zinc oxide.

9. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation contains one or more UV filters a) in a total concentration of 1 to 30% by weight, based on the total weight of the preparation.

10. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation is in the form of a spray.

11th Cosmetic preparation, method or use according to one of the preceding claims 1 to 9, characterized in that the preparation is in the form of an emulsion or an alcoholic preparation.

12. Cosmetic preparation, method or use according to claim 10, characterized in that the emulsion is spray formulation

Cetyl palmitate (INCI: Cetyl Palmitate) in a concentration of 0.1 to 2.5% by weight and a wax with a melting point of 68-80 ° C in a concentration of 0.1 to 2.5% by weight and hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) in a concentration of 0.5 to 3% by weight, based in each case on the total weight of the preparation.

13. Cosmetic preparation, method or use according to claim 11, characterized in that the emulsion

Cetyl palmitate (INCI: Cetyl Palmitate) in a concentration of 0.1 to 2.5%, a wax with a melting point of 68-75 ° C in a concentration of 0.1 to 2.5

% By weight and hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) in a concentration of 0.5 to 3% by weight, each based on the total weight of the preparation.

14. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation contains xanthan gum (INCI: Xanthan Gum) in a concentration of 0.01 to 0.5, based on the total weight of the preparation.

15. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation contains phenoxyethanol, ethylhexylglycerol and / or 4-hydroxyacetophenone.

16. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation contains one or more alkanediols from the group of compounds 1, 2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2 - Contains decanediol, 2-methyl-1,3-propanediol.

17. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation is free of 3- (4- methylbenzylidene) camphor, 2-hydroxy-4-methoxybenzophenone (INCI: Oxybenzone), 4- methoxycinnamic acid 2-ethylhexyl ester (INCI Octylmethoxycinnamate),

Parabens, methyl isothiazolinone, chloromethyl isothiazolinone and DMDM hydantoin, polyethylene glycol ethers or polyethylene glycol esters.